Form 4 for ENOV Enovis CORP

Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-27 · accession 0001209191-23-014364 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-03-01	2023-02-27+	ENOV	Tandy Bradley J	SVP, GC	A - Grant	$0.00	+6,981	17.1K	+69%	$0
D	2023-03-01	2023-02-27	ENOV	Tandy Bradley J	SVP, GC	S - Sale	$56.08	-2,491	13.5K	-16%	-$139.7K
D	2023-03-01	2023-02-28	ENOV	Tandy Bradley J	SVP, GC	A - Grant	$0.00	+8,604	8,604	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock, par value $0.001	2023-02-27	A	A	3,353	$0.00	15,974	D	—	—	(F1) Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022.
2	Common	Common stock, par value $0.001	2023-02-28	A	A	3,628	$0.00	17,111	D	—	—	(F3) This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
3	Common	Common stock, par value $0.001	2023-02-27	S	D	2,491	$56.08	13,483	D	—	—	(F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units.
4	Derivative	Employee Stock Option (right to buy)	2023-02-28	A	A	8,604	$0.00	8,604	D	$57.62 · — to 2030-02-27	8,604 Common stock, par value $0.001	(F4) The option vests in three equal annual installments beginning on the first anniversary of the grant date.